Vimarsana
Biggest News Aggregation in the World

Page 48 - Structural Heart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Structural Heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Structural Heart Today - Breaking & Trending Today

Abbott Laboratories (ABT) Q3 2021 Earnings Call Transcript - Vimarsana News

Abbott Laboratories (ABT) Q3 2021 Earnings Call Transcript

ABT earnings call for the period ending September 30, 2021.

Source: fool.com
Abbott Reports Third-Quarter 2021 Results; Achieves Strong Double-Digit Earnings Growth and Raises Guidance - Vimarsana News

Abbott Reports Third-Quarter 2021 Results; Achieves Strong Double-Digit Earnings Growth and Raises Guidance

/PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2021. Third-quarter sales of $10.9 billion increased...

Peijia Medical Partners with inQB8 for US Incubator and Transcatheter Tricuspid Replacement (TTVR) Product - Vimarsana News

Peijia Medical Partners with inQB8 for US Incubator and Transcatheter Tricuspid Replacement (TTVR) Product

/PRNewswire/ -- Peijia Medical (HKEX:9996, or "Peijia"), a leading player in China for medical technology, announced a partnership with inQB8, a Boston based...

Peijia Medical Partners with inQB8 for US Incubator and Transcatheter Tricuspid Replacement (TTVR) Product - Vimarsana News

Peijia Medical Partners with inQB8 for US Incubator and Transcatheter Tricuspid Replacement (TTVR) Product

/PRNewswire/ -- Peijia Medical (HKEX:9996, or "Peijia"), a leading player in China for medical technology, announced a partnership with inQB8, a Boston based...

AdjuCor Raises € 29 Million in Series B Funding Round for its Revolutionary Heart Assist Technology that Completely Avoids Blood Contact - Vimarsana News

AdjuCor Raises € 29 Million in Series B Funding Round for its Revolutionary Heart Assist Technology that Completely Avoids Blood Contact

AdjuCor Raises € 29 Million in Series B Funding Round for its Revolutionary Heart Assist Technology that Completely Avoids Blood Contact Share Article AdjuCor raises € 29 million to enable its next phase of bringing its revolutionary heart assist technology to the severely underserved end-stage heart failure patients. This Series B financing round includes € 25 million from the cardiovascular-focused medical device platform company MitrAssist Holdings Limited accompanied by an additional € 4 million from the returning investor Maurizio Group. AdjuCor's revolutionary technology provide...

Source: prweb.com